2025-522571-28-00CompletedPhase 1
A study to evaluate how well single and multiple doses of O3R-5671-PRO are tolerated in healthy adult subjects
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Jul 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 96 (actual)
- First submitted
- 1 Jul 2025
- Start date
- 28 Aug 2025
- Lead sponsor
- Coultreon Biopharma
- EU CT number
- 2025-522571-28-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 96
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.